MedPath

TRIKAFTA

TRIKAFTA

Approved
DIN Number

02542285

Drug Class

Human

Market Date

Oct 27, 2023

Company
HC

Vertex Pharmaceuticals (Canada) Incorporated

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02542285
AIG Number0462989004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R07AX32 IVACAFTOR, TEZACAFTOR AND ELEXACAFTOR
Product Specifications
Dosage FormGranules
Route of AdministrationOral
AHFS Classification48:14.04
Health Canada Classification

ACTIVE INGREDIENTS (4)

ELEXACAFTORActive
Strength: 80 MG
Monograph: ELEXACAFTOR
IVACAFTORActive
Strength: 59.5 MG
Monograph: IVACAFTOR
IVACAFTORActive
Strength: 60 MG
Monograph: IVACAFTOR
TEZACAFTORActive
Strength: 40 MG
Monograph: TEZACAFTOR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.